News
With the decline in UK public health campaign funding, we have explored the unique opportunity presented to the ...
In a significant step towards tackling one of the UK’s most underdiagnosed conditions, North East and North Cumbria ...
AbbVie’s Elahere (mirvetuximab soravtansine) has been approved by the Medicines and Healthcare products Regulatory Agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results